The role of self-monitoring of blood glucose in glucagon-like peptide-1-based treatment approaches: A European expert recommendation

Oliver Schnell, Hasan Alawi, Tadej Battelino, Antonio Ceriello, Peter Diem, Anne Marie Felton, Wladyslaw Grzeszczak, Kari Harno, Peter Kempler, Ilhan Satman, Bruno Verges̀

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

The role of glucagon-like peptide (GLP)-1-based treatment approaches for type 2 diabetes mellitus (T2DM) is increasing. Although self-monitoring of blood glucose (SMBG) has been performed in numerous studies on GLP-1 analogs and dipeptidyl peptidase-4 inhibitors, the potential role of SMBG in GLP-1-based treatment strategies has not been elaborated. The expert recommendation suggests individualized SMBG strategies in GLP-1-based treatment approaches and suggests simple and clinically applicable SMBG schemes. Potential benefits of SMBG in GLP-1-based treatment approaches are early assessment of treatment success or failure, timely modification of treatment, detection of hypoglycemic episodes, assessment of glucose excursions, and support of diabetes management and diabetes education. Its length and frequency should depend on the clinical setting and the quality of metabolic control. It is considered to play an important role for the optimization of diabetes management in T2DM patients treated with GLP-1-based approaches.

Original languageEnglish
Pages (from-to)665-673
Number of pages9
JournalJournal of Diabetes Science and Technology
Volume6
Issue number3
DOIs
Publication statusPublished - May 2012

Keywords

  • Diabetes
  • Dipeptidyl peptidase-4 inhibitors
  • Glucagon-like peptide-1 analogs
  • Hypoglycemia
  • Self-monitoring
  • Treatment

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Bioengineering
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'The role of self-monitoring of blood glucose in glucagon-like peptide-1-based treatment approaches: A European expert recommendation'. Together they form a unique fingerprint.

  • Cite this

    Schnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A. M., Grzeszczak, W., Harno, K., Kempler, P., Satman, I., & Verges̀, B. (2012). The role of self-monitoring of blood glucose in glucagon-like peptide-1-based treatment approaches: A European expert recommendation. Journal of Diabetes Science and Technology, 6(3), 665-673. https://doi.org/10.1177/193229681200600323